SARS-CoV-2 Testing Finds Fewer Infections

Scientists continue to learn more about COVID-19 and COVID-19 immunity. As of Feb. 25, 2022, the U.S. FDA confirmed it had authorized 419 tests and sample collection devices and 847 related revisions.

Overall, 813,578,612 results tests have been reported.

Regarding current testing trends, the U.S. CDC reported that on Feb. 25, 2022, the percentage of COVID-19 NAATs found positive is decreasing compared to the previous week.

The 7-day average of percent positivity from NAATs was 5.4% last week.

The previous 7-Day average was 8.3%.

To empower people to make informed testing decisions, the FDA recently updated the Antibody Testing for COVID-19: Information for Patients and Consumers.

The update includes information about:

• Antibodies and Antibody Tests: The Basics
• Antibody Tests: Not for Use to Check Immunity
• Antibody Tests: Results and Terms

Updated FAQs are found on this webpage.